Connect Biopharma Limited
CNTB | NASDAQ
$1.23
-$0.09 (-6.82%)
Sep 22, 2026, 2:40 PM ET · Market open
Market Data
Market Cap $83.11M
Enterprise Value $52.22M
Beta -0.22
Average Volume 487.25K
Shares Outstanding (Diluted) 62.88M
Shares Change YoY 13.19%
Institutional Ownership 22.90%
Exchange NASDAQ
ISIN KYG235491019
Price Performance
Price Change 1M -43.4%
Price Change 3M -36.8%
Price Change 6M -60.7%
Price Change YTD -47.6%
Price Change 1Y -16.5%
Price Change 3Y 81.3%
Price Change 5Y -93.9%
1M CAGR (ann.) -40.3%
1Y CAGR (ann.) -18.0%
5Y CAGR (ann.) -43.1%
All-Time CAGR -38.0%
Valuation
PE Ratio -2.44
Forward PE N/A
PEG Ratio 0.02
Forward PEG 0.10
PS Ratio N/A
Forward PS 5.60
PB Ratio 3.09
P/FCF Ratio -2.60
P/Adj. FCF Ratio -2.42
P/OCF Ratio -2.59
EV/Sales N/A
EV/EBIT -3.46
EV/EBITDA -1.61
EV/FCF -1.64
Earnings Yield -40.9%
FCF Yield -38.4%
Adj. FCF Yield -41.4%
Financial Health
Net Cash $30.89M
Total Debt $596K
Cash & Short-Term Investments $31.49M
Total Assets $43.47M
Current Ratio 2.37
Quick Ratio 2.37
Debt / Equity Ratio 0.02
Debt / EBITDA -0.02
Debt / FCF -0.02
OCF / Debt -53.57
Interest Coverage 0.00
Altman Z-Score -11.62
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -1795.6%
EBITDA Margin -1763.3%
Net Profit Margin -1763.4%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 83.8%
SBC Impact (per share) -7.7%
Returns
Return on Assets -119.1%
Return on Equity -150.5%
Return on Invested Capital -191.3%
Return on Capital Employed -194.1%
Return on Tangible Assets -119.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 0.0%
Revenue CAGR 5Y 50.1%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 135.8%
EPS CAGR 5Y 74.3%
EPS CAGR 10Y N/A
FCF CAGR 3Y 65.3%
FCF CAGR 5Y 25.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 6
EPS Growth Next 3Y -4.9%
Revenue Growth Next 3Y N/A
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.27
EPS Growth Est (next Q) 518.7%
Revenue Est (next Q) $115.74K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $6.60
Price Target Upside 400.0%
Cash Flow
Operating Cash Flow $-31.93M
Free Cash Flow $-31.93M
Adj. Free Cash Flow $-34.39M
FCF Per Share -$0.51
OCF Per Share -$0.51
OCF/S Ratio -1087.1%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-33.13M
EBITDA $-32.51M
Net Income $-32.39M
EPS (Diluted) -$0.54
Revenue / Employee N/A
Profit / Employee $-506.14K
Employees 64
Add to Watchlist
Select watchlists to add or remove CNTB